December 02, 2016 05:30 AM Eastern Standard Time SEATTLE–(BUSINESS WIRE) Impel NeuroPharma, Inc., a Seattle based clini...
What We Do
Impel is using its Precision Olfactory Delivery (POD) nasal devices to develop therapies for Alzheimer’s, migraine, and other diseases of the brain. The POD devices target drug to the upper nasal cavity to improve drug delivery to the brain. The POD technology is compatible with numerous formulations and drug types. Impel has three proprietary products in clinical development, plus two further programs ready to enter clinic. In addition, Impel partners with pharma and biotech companies and is actively engaged in co-development programs in this space.
Learn how our POD technology can improve drug delivery to the brain